Table 2 |
||||
|
Upregulated genes in MCF-7 cells after exposure to rapamycin plus CN-A for 12 hours |
||||
|
Gene expression ratio |
||||
|
|
||||
|
GenBank number |
Gene name |
Rapamycin + CN-A |
Rapamycin |
CN-A |
|
|
||||
|
Transforming growth factor-β-induced 68 kDa (TGFBI) |
8.16 |
1.74 |
5.2 |
|
|
Sodium channel, nonvoltage-gated 1α(SCNN1A) |
6.99 |
1.49 |
4.26 |
|
|
Keratin, hair, basic-1 (KRTHB1) |
6.96 |
1.27 |
12.8a |
|
|
BCL2-interacting killer (apoptosis-inducing; BIK) |
6.76 |
2.37 |
3.59 |
|
|
Cyclin G2 (CCNG2) |
6.08 |
3.07 |
3.22 |
|
|
Growth factor receptor-bound protein 7 (GRB7) |
5.81 |
2.48 |
2.61 |
|
|
KIAA1536 protein (KIAA1536) |
5.42 |
2.78 |
1.8 |
|
|
Solute carrier family 2, member 10 (SLC2A10) |
5.09 |
1.53 |
2.51 |
|
|
Tetraspan 1 (TSPAN-1) |
4.61 |
1.54 |
1.76 |
|
|
Hypothetical protein FLJ14146 (FLJ14146) |
4.55 |
1.8 |
2.53 |
|
|
Cytoplasmic FMR1 interacting protein 2 (CYFIP2) |
4.21 |
2.43 |
1.66 |
|
|
Hypothetical protein FLJ20059 (FLJ20059) |
4.09 |
1.51 |
1.2 |
|
|
Inhibitor of DNA binding 2 (ID2) |
4.03 |
1.23 |
2.93 |
|
|
Proline rich 2 (PROL2) |
3.87 |
2.8 |
1.9 |
|
|
RAP1, GTPase activating protein 1 (RAP1GA1) |
3.81 |
1.56 |
2.51 |
|
|
Carnitine acetyltransferase (CRAT) |
3.79 |
1.75 |
2.45 |
|
|
Hypothetical protein MGC10500 (MGC10500) |
3.72 |
2.18 |
2.29 |
|
|
HMG-box containing protein 1 (HBP1) |
3.7 |
1.67 |
1.55 |
|
|
Latexin protein (LXN) |
3.68 |
2.49 |
2.40 |
|
|
BCL2 binding component 3 (BBC3) |
3.55 |
1.82 |
2.18 |
|
|
GalNAc-T12 (GALNT12) |
3.49 |
1.49 |
2.53 |
|
|
Inhibitor of growth family, member 4 (ING4) |
3.47 |
1.98 |
1.73 |
|
|
Chromosome 1 open reading frame 26 (C1orf26) |
3.45 |
1.44 |
2.93 |
|
|
RAB26, member RAS oncogene family (RAB26) |
3.42 |
2.40 |
1.49 |
|
|
B-cell CLL/lymphoma 3 (BCL3) |
3.39 |
1.05 |
3.31 |
|
|
|
||||
|
aIncreased upper reliable levels. CN-A, cotylenin A. |
||||
|
Kasukabe et al. Breast Cancer Research 2005 7:R1097 doi:10.1186/bcr1344 |
||||